SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-18-023237
Filing Date
2018-04-27
Accepted
2018-04-27 17:21:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A tv491818_s3a.htm S-3/A 50090
2 EXHIBIT 23.1 tv491818_ex23-1.htm EX-23.1 2387
3 EXHIBIT 23.2 tv491818_ex23-2.htm EX-23.2 2093
  Complete submission text file 0001144204-18-023237.txt   55637
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-223856 | Film No.: 18785599
SIC: 8731 Services-Commercial Physical & Biological Research